Brimonidine Tartrate Solution/ Drops
Product Images NDC 70069-233

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Brimonidine Tartrate (NDC 70069-233). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Somerset Therapeutics, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

735ec3d0 3e39 41fd 96b1 5ae5c303b714 01

735ec3d0 3e39 41fd 96b1 5ae5c303b714 01
Chemical structure of Brimonidine Tartrate, showing the molecular arrangement of brimonidine and tartrate components as depicted in the image.*
FDA Label Image

735ec3d0 3e39 41fd 96b1 5ae5c303b714 02

735ec3d0 3e39 41fd 96b1 5ae5c303b714 02
Label for Brimonidine Tartrate Ophthalmic Solution 0.2% (2 mg/mL) in a 5 mL bottle. The label includes active ingredient concentration, preservative benzalkonium chloride (0.005%), storage instructions, and is marked for ophthalmic use only. Manufactured by Somerset Therapeutics, LLC, Hollywood, FL, and made in India. Barcode and NDC 70069-231-01 are also visible.*
FDA Label Image

735ec3d0 3e39 41fd 96b1 5ae5c303b714 03

735ec3d0 3e39 41fd 96b1 5ae5c303b714 03
Label for Brimonidine Tartrate Ophthalmic Solution 0.2%, an eye drop solution in a 5 mL container. The label shows the product is Rx only with active ingredient Brimonidine tartrate 0.2%, manufactured for Somerset Therapeutics LLC. It includes usage warnings and storage instructions, with the product for ophthalmic use only.*
FDA Label Image

735ec3d0 3e39 41fd 96b1 5ae5c303b714 04

735ec3d0 3e39 41fd 96b1 5ae5c303b714 04
Brimonidine Tartrate Ophthalmic Solution 0.2% label showing active ingredient concentration (0.2%), preservative (Benzalkonium chloride 0.005%), storage instructions (store between 15°-25°C), and volume (10 mL). Labeled for ophthalmic use and manufactured for Somerset Therapeutics, LLC, Hollywood, FL, with a barcode and NDC 70069-232-01.*
FDA Label Image

735ec3d0 3e39 41fd 96b1 5ae5c303b714 05

735ec3d0 3e39 41fd 96b1 5ae5c303b714 05
Label for Brimonidine Tartrate Ophthalmic Solution 0.2%, a 10 mL eye drop solution by Somerset Therapeutics, LLC. The label shows the active ingredient concentration, usage instructions for eye application, storage conditions, and manufacturer information including a barcode and customer care contact.*
FDA Label Image

735ec3d0 3e39 41fd 96b1 5ae5c303b714 06

735ec3d0 3e39 41fd 96b1 5ae5c303b714 06
Label for Brimonidine Tartrate Ophthalmic Solution 0.2%, a prescription eye drop solution. The 15 mL label states active ingredient Brimonidine tartrate 0.2%, preservative benzalkonium chloride 0.005%, storage instructions, and manufacturing information for Somerset Therapeutics, LLC, Hollywood, FL. The label includes the NDC 70069-233-01 and usage instructions "For use in the eyes only."*
FDA Label Image

735ec3d0 3e39 41fd 96b1 5ae5c303b714 07

735ec3d0 3e39 41fd 96b1 5ae5c303b714 07
Label for Brimonidine Tartrate Ophthalmic Solution 0.2%, a 15 mL eye drop solution by Somerset Therapeutics, LLC. The label shows active ingredient concentration, manufacturer information, and usage instructions emphasizing prescription use and eye application. It includes storage guidelines and a warning about contamination risk from touching the dropper tip.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.